W Sizoo

1.0k total citations
38 papers, 787 citations indexed

About

W Sizoo is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, W Sizoo has authored 38 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 13 papers in Oncology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in W Sizoo's work include Acute Myeloid Leukemia Research (19 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Acute Lymphoblastic Leukemia research (9 papers). W Sizoo is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Acute Lymphoblastic Leukemia research (9 papers). W Sizoo collaborates with scholars based in Netherlands, Norway and Sweden. W Sizoo's co-authors include Bob Löwenberg, Anton Hagenbeek, A Hagemeijer, K. Hählen, J. Abels, W. D. H. Hendriks, K. Sintnicolaas, Pieter Sonneveld, Gerard Wagemaker and R. L. H. Bolhuis and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

W Sizoo

37 papers receiving 740 citations

Peers

W Sizoo

HEMAT

ONCOL

PHEOH

PFM

GENET

A Iriondo Spain

SJ Forman United States

Walter Feremans Belgium

Lyubica Dabich United States

N Gratecos France

BJ Bolwell United States

Jean Paul Vernant France

PM Parker United States

JM Rowe United States

AP Nademanee United States

A Iriondo Spain

W Sizoo

625 ×1.4

HEMAT

255 ×1.0

ONCOL

190 ×0.8

PHEOH

159 ×1.1

PFM

130 ×1.0

GENET

Citations per year, relative to W Sizoo W Sizoo (= 1×) peers A Iriondo

Countries citing papers authored by W Sizoo

Since Specialization

Citations

This map shows the geographic impact of W Sizoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Sizoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Sizoo more than expected).

Fields of papers citing papers by W Sizoo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Sizoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Sizoo. The network helps show where W Sizoo may publish in the future.

Co-authorship network of co-authors of W Sizoo

This figure shows the co-authorship network connecting the top 25 collaborators of W Sizoo. A scholar is included among the top collaborators of W Sizoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Sizoo. W Sizoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dekker, A. W., Mars B. vanʼt Veer, W Sizoo, et al.. (1997). Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group.. Journal of Clinical Oncology. 15(2). 476–482. 49 indexed citations

Gratama, Jan W., M. A. P. Oosterveer, W. Weimar, et al.. (1994). Detection of multiple 'Ebnotypes' in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx. Journal of General Virology. 75(1). 85–94. 42 indexed citations

Veer, Mars B. vanʼt, Wim L.J. van Putten, LF Verdonck, et al.. (1993). Acute lymphoblastic leukaemia in adults: Immunological subtypes and clinical features at presentation. Annals of Hematology. 66(6). 277–282. 10 indexed citations

Aelst, F. Van, Bob Löwenberg, W Sizoo, et al.. (1993). Allogeneic bone marrow transplantation for chronic myelogenous leukemia. European Journal of Cancer. 29. S150–S150.

Meerwaldt, J.H., Patrice Carde, J. M. V. Burgers, et al.. (1991). Low-dose total body irradiation versus combination chemotherapy for lymphomas with follicular growth pattern. International Journal of Radiation Oncology*Biology*Physics. 21(5). 1167–1172. 28 indexed citations

Löwenberg, Bob, Wim L.J. van Putten, Leo F. Verdonck, et al.. (1990). Autologous Bone Marrow Transplantation in Acute Myeloid Leukemia in First Remission: First Dutch Prospective Study. Hämatologie und Bluttransfusion. 33. 655–659. 2 indexed citations

Ruit, Jan B., Bob Löwenberg, Anton Hagenbeek, et al.. (1990). Phase II study of lomustine, cytarabine, mitoxantrone, and prednisone (CAMP) combination chemotherapy for doxorubicin-resistant intermediate- and high-grade malignant non-Hodgkin's lymphoma.. PubMed. 17(6 Suppl 10). 24–7. 5 indexed citations

Sizoo, W, et al.. (1988). Myelodysplastic syndromes: Analysis of clinical and prognostic features in 96 patients. European Journal Of Haematology. 41(2). 115–122. 26 indexed citations

Sizoo, W, et al.. (1988). Myelodysplastic syndromes: Analysis of morphological features related to the FAB‐classification. European Journal Of Haematology. 41(1). 58–61. 12 indexed citations

10.

Sonneveld, Pieter, et al.. (1988). Cellular pharmacokinetics of daunorubicin: relationships with the response to treatment in patients with acute myeloid leukemia.. Journal of Clinical Oncology. 6(5). 802–812. 36 indexed citations

11.

Maschmeyer, Georg, E. Haralambie, Wilhelm Gaus, et al.. (1988). Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia. Infection. 16(2). 98–104. 44 indexed citations

12.

Sizoo, W, et al.. (1988). Non-Hodgkin's lymphoma of the corpus vitreum.. PubMed. 33(1-2). 26–9. 1 indexed citations

13.

Sonneveld, Pieter, et al.. (1988). In vivo uptake of daunorubicin by acute myeloid leukemia (AML) cells measured by flow cytometry.. PubMed. 2(8). 511–7. 15 indexed citations

14.

Sonneveld, Pieter, et al.. (1987). Concentrations of ciclosporin in allogeneic bone marrow recipients. Annals of Hematology. 55(5). 467–472. 2 indexed citations

15.

Vellenga, Edo, W Sizoo, Anton Hagenbeek, & Bob Löwenberg. (1987). Different repopulation kinetics of erythroid (BFU-E), myeloid (CFU-GM) and T lymphocyte (TL-CFU) progenitor cells after autologous and allogeneic bone marrow transplantation. British Journal of Haematology. 65(2). 137–142. 26 indexed citations

16.

Hagemeijer, A, R. L. H. Bolhuis, Jacques J. M. van Dongen, & W Sizoo. (1986). Simultaneous occurrence of acute monoblastic leukemia and an abnormal B‐cell clone with both cell types characterized by specific cytogenetic and immunological markers. Scandinavian Journal of Haematology. 36(5). 484–491. 4 indexed citations

17.

Kluin‐Nelemans, Hanneke C., R. L. H. Bolhuis, Bob Löwenberg, Dario Campana, & W Sizoo. (1986). Characterization of normal and regenerating bone marrow cells with a panel of monoclonal antibodies. Scandinavian Journal of Haematology. 36(1). 71–78. 9 indexed citations

18.

Carde, Patrice, J. M. V. Burgers, M. van Glabbeke, et al.. (1984). Combined radiotherapy-chemotherapy for early stages non-Hodgkin'slymphoma: The 1975–1980 EORTC controlled lymphoma trial. Radiotherapy and Oncology. 2(4). 301–312. 51 indexed citations

19.

Hagemeijer, A, W Sizoo, E.M.E. Smit, & J. Abels. (1981). Translocation (5p;17q) in blast crisis of chronic myeloid leukemia. Cytogenetic and Genome Research. 30(4). 205–210. 2 indexed citations

20.

Sizoo, W, et al.. (1976). Leukaemia of the myeloid series in patients with Hodgkin's disease.. PubMed. 19(4-5). 234–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact